HH Biotechnology Holdings Co operates in the Nonresidential building operators sector.
In addition to historical fundamental analyses, the complete report available to purchase compares HH Biotechnology Holdings Co with three other
Real estate operators in Asia:
Henry Group Holdings Limited
of Hong Kong
sales of 51.27 million Hong Kong Dollars [US$6.61 million]
Tan Binh Import Export Joint Stock Corp
(181.69 billion Dong [US$8.14 million]
Trus Y 7 Reit Co Ltd
based in South Korea
(7.46 billion Korean Won [US$6.66 million]
HH Biotechnology Holdings Co reported sales of 50.24 million Chinese Renmimbi (US$7.46 million)
December of 2015.
a very small
increase of 2.0%
versus 2014, when the company's sales were 49.28 million Chinese Renmimbi.
This was the fourth straight year of sales growth at HH Biotechnology Holdings Co.
The sales level in 2015 was fairly close to the level five years ago: in 2010, HH Biotechnology Holdings Co had sales
of 51.44 million Chinese Renmimbi.